Skip to main content

NVO Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Novo Nordisk A/S News

Novo Nordisk Agrees to Buy Dicerna Pharma for $3.3 Billion

Discerna Pharma shares jump 78% after Novo Nordisk agrees to buy the company, with the deal expected to close in the fourth quarter of 2021.

Walmart Launches Low-Priced Private Brand Insulin In Latest Healthcare Push

Walmart will sell insulin made by Novo Nordisk under its own private label, and at a lower price, as it continues to push growth in its healthcare business.

Eli Lilly Shares Climb; Morgan Stanley Upgrades Drugmaker to Overweight and Lifts Price Target

Analyst David Risinger expects the Indianapolis firm to post higher revenue and fatter profit margins. And he's optimistic about its diabetes- and psoriasis-treatment offerings.

UniQure Jumps on Report It's Exploring a Possible Sale

A report says the biotechnology company is exploring options including a potential sale amid interest from pharmaceutical companies looking to expand in gene therapy.

Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs

Gilead Sciences is partnering with Novo Nordisk to help combat liver disease.

Breaking News

Costco May Have a Huge Workers Problem

Workers demand for their needs to be met.

Real Estate Titan Zillow Sees Tough Times Ahead in Housing

The residential real estate market has stumbled, after soaring in the first 18 months of the covid pandemic.

Elon Musk Has Bad News About Tesla's Cybertruck

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023